NVO Total Current Liabilities

Novo Nordisk A/S Common Stock · Total Current Liabilities

NVO logo

NVO Total Current Liabilities

Latest reportedkr 239.08B DKK
NVO Quarterly Current Liabilities · DKK (kr 1.60B → kr 239.08B)
High-resolution chart · PNG

NVO total current liabilities history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Total Current Liabilities — Quarterly (DKK)
Period endingTotal Current Liabilities (DKK)
239,083,000,000
225,158,000,000
215,661,000,000
234,358,000,000
207,522,000,000
236,117,000,000
217,528,000,000
208,358,000,000
27,005,403,696
165,606,000,000
169,655,000,000
24,499,091,322
22,948,196,663
19,245,976,475
120,940,000,000
17,161,886,190
15,415,380,938
14,300,223,623
99,516,000,000
13,766,618,350
11,609,507,937
11,438,775,590
11,551,409,550
11,176,873,695
10,139,316,902
9,291,112,810
8,860,297,431
63,087,000,000
56,595,000,000
54,760,000,000
54,164,000,000
49,425,000,000
49,179,000,000
44,168,000,000
47,056,000,000
45,127,000,000
43,824,000,000
48,903,000,000
47,436,000,000
41,592,000,000
41,528,000,000
41,074,000,000
40,873,000,000
38,523,000,000
38,593,000,000
41,989,000,000
33,689,000,000
30,031,000,000
23,748,000,000
26,397,000,000
24,225,000,000
25,659,000,000
25,420,000,000
25,626,000,000
21,638,000,000
26,226,000,000
23,853,000,000
21,993,000,000
20,779,000,000
20,355,000,000
18,600,000,000
18,253,000,000
18,476,000,000
16,929,000,000
18,288,000,000
15,520,000,000
13,415,000,000
12,935,000,000
12,475,000,000
14,141,000,000
12,987,857,600
12,306,393,400
11,028,351,100
11,586,438,300
10,657,576,000
10,764,809,100
10,550,630,300
10,654,090,820
10,159,778,800
11,493,447,540
10,227,475,200
10,508,548,050
10,565,470,480
9,317,056,200
8,930,106,950
7,448,513,760
7,331,714,160
7,265,049,460
6,678,465,040
6,936,204,520
6,645,874,800
5,959,414,980
5,989,825,170
6,416,960,000
6,564,992,880
5,485,636,926
5,314,656,924
3,673,564,727
3,937,036,800
4,578,917,700
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.